- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.12. | FDA clears trial of 'vectorised' ALS antibody from VectorY | ||
| 03.12. | AZ uses a priority review voucher for baxdrostat filing | ||
| 03.12. | FDA takes steps to limit non-human primate testing | ||
| 02.12. | Pazdur to leave FDA, shortly after taking CDER job | ||
| 02.12. | J&J gets EU approval for Imaavy in gMG | ||
| 02.12. | Bayer aims Mirena at women's health issue with no treatment | ||
| 02.12. | FDA doubles down on its push into AI | ||
| 02.12. | Slow recruitment still hitting UK trials, says pharma | ||
| 01.12. | UK and US agree zero tariffs on pharma - with price rises | ||
| 01.12. | EMA starts review of 'transformative' bladder cancer therapy | ||
| 01.12. | Belite plans filing for oral Stargardt drug after phase 3 win | ||
| 01.12. | Real-world trial of Lilly's tirzepatide starts in UK | ||
| 01.12. | Is FDA about to restrict vaccination even further? | ||
| 01.12. | Limited prostate cancer screening backed in UK | ||
| 28.11. | Veraxa says delayed US listing is back on track | ||
| 28.11. | Innovent gets OK for China's first home-grown IL-23p19 drug | ||
| 28.11. | Digital platform for GPs 'could transform clinical trials' | ||
| 28.11. | Wellcome donates £2m to UK's digital mental health drive | ||
| 28.11. | Tonix launches its new fibromyalgia drug in US | ||
| 27.11. | Wearable alert system for epileptics set for European launch | ||
| 27.11. | Vaderis drug lends hope to patients with bleeding disease HHT | ||
| 27.11. | Platform tests commercial algorithms for NHS use for bias | ||
| 27.11. | FDA starts priority review of BeOne's Venclexta rival | ||
| 27.11. | Lundbeck bows out of bidding war for Avadel | ||
| 26.11. | Novo Nordisk spends priority voucher on Wegovy filing |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .